Prostate cancer — all decisions

The Board denied the veteran's claims for increased ratings and other benefits, finding that his conditions did not meet the criteria for higher ratings.

The Board denied the Veteran's claim for a total disability rating based on individual unemployability due to service-connected disabilities, as the evidence did not show that his service-connected conditions rendered him unable to secure or follow substantially gainful employment.

The Board granted service connection for basal cell carcinoma and a residual scar of the posterior neck, as secondary to the Veteran's service-connected basal cell carcinoma. The appeal for an earlier effective date for prostate cancer was dismissed.

The Board remands the claims for service connection for prostate cancer and multiple myeloma to correct predecisional duty to assist errors.

The Board granted service connection for a right shoulder condition, bilateral toenail fungus and athlete's foot, pseudofolliculitis barbae, and furuncle incision and drainage healed scar (claimed as cyst removal on buttocks with scar), but denied an increased rating in excess of 50 percent for sleep apnea with asthma associated with allergic rhinitis. The claims for service connection for prostate cancer and gum disease were remanded.

The Board denied the veteran's claims for service connection for prostate cancer and leukocytosis, finding no medical link between these conditions and his active-duty service.

The Board granted an initial 40 percent evaluation for service-connected residuals of prostate cancer, effective from the date of claim. The other issues were remanded.

The Board granted service connection for prostate cancer, finding it to be related to the Veteran's exposure to contaminants in the water supply at Camp Lejeune.

The Board remands the claims for service connection for prostate cancer, brain cancer, and erectile dysfunction to verify in-service toxic exposure other than asbestos and Agent Orange.

The Board granted service connection for bladder cancer, prostate cancer, and erectile dysfunction as secondary to the service-connected prostate cancer.

The Board remands the case to obtain an adequate VA examination to determine the current severity of the Veteran's prostate cancer and clarify whether it is active or in remission.

The Board remands the claim for service connection for prostate cancer to verify the Veteran's claimed exposure to herbicide agents during active military service in Korea and to obtain a VA examination.

The Board denied service connection for prostate cancer and coronary calcification, finding no evidence of a medical nexus between the conditions and toxic exposure or service.

The Board remands the claims for service connection for diabetes type II, GERD, prostate cancer, and hypertension as further development is necessary to determine if there is a nexus between these conditions and the Veteran's military service, including exposure to herbicides.

The Board granted earlier effective dates of April 28, 2017, for service connection for diabetes mellitus, type II, right and left lower extremity peripheral neuropathy, and a total disability rating based on unemployability due to service-connected disabilities (TDIU), but denied an earlier effective date for prostate cancer residuals.

The Board remands the claim for service connection of prostate cancer to obtain an addendum opinion that addresses the Veteran's contention of a link between his condition and in-service exposure.

The Veteran's claim for special monthly compensation (SMC) based on the need for regular aid and attendance due to his service-connected disabilities was granted.

The Board remands the claims for service connection for prostate and throat cancers due to a lack of proper development regarding potential exposures to PFAS and herbicides during active duty.

The Board remands the claims for an increased rating and earlier effective date for the Veteran's heart disability, an increased rating for prostate cancer, SMC based on the need for aid and attendance, and an earlier effective date for TDIU due to inadequate VA examinations.

The Board granted a 100 percent rating for prostate cancer due to its recurrence during the appeal period.